logo
搜索
菜单

视频 在线看

当前174/1397页
排序: 今日浏览数
25.10: Oral Hypoglycemic Agents: Sulfonylureas 01:17 min
25.10: Oral Hypoglycemic Agents: Sulfonylureas
25.9: Insulin: Dosing Regimen and Adverse Effects 01:16 min
25.9: Insulin: Dosing Regimen and Adverse Effects
25.8: Insulin Formulations: Types and Delivery 01:27 min
25.8: Insulin Formulations: Types and Delivery
25.3: Insulin: The Receptor and Signaling Pathways 01:28 min
25.3: Insulin: The Receptor and Signaling Pathways
17.3: Drug Toxicity: Dose-Dependent Reactions 01:24 min
17.3: Drug Toxicity: Dose-Dependent Reactions
16.14: Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices 01:28 min
16.14: Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices
15.7: Pharmacokinetic–Pharmacodynamic Relationship: Model Components 01:14 min
15.7: Pharmacokinetic–Pharmacodynamic Relationship: Model Components
15.2: Pharmacokinetic–Pharmacodynamic Relationship: Dose to Pharmacological Effect 01:28 min
15.2: Pharmacokinetic–Pharmacodynamic Relationship: Dose to Pharmacological Effect
14.9: Pharmacogenomics: Identification of New Drug Targets 01:29 min
14.9: Pharmacogenomics: Identification of New Drug Targets
14.7: Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters 01:16 min
14.7: Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters
14.5: Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes 01:28 min
14.5: Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes
13.22: Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant 01:25 min
13.22: Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
13.18: Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment 01:08 min
13.18: Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
13.16: Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug 01:14 min
13.16: Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug
13.15: Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow 01:26 min
13.15: Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
13.12: Pharmacokinetics in Pediatric Patients: Drug Distribution 01:17 min
13.12: Pharmacokinetics in Pediatric Patients: Drug Distribution
13.10: Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion 01:20 min
13.10: Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
13.6: Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism 01:18 min
13.6: Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
13.2: Drug Dosing: Obese Patients 01:21 min
13.2: Drug Dosing: Obese Patients
12.18: Pharmacokinetics: Drug–Food and Drug–Viral Interactions 01:26 min
12.18: Pharmacokinetics: Drug–Food and Drug–Viral Interactions
返回顶部